drugset / Trial / NCT00915837

Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema

NCT00915837

Phase 1 Completed 31 enrolled SurModics, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This Phase 1 study will evaluate the safety, tolerability and duration of effect of a helical intravitreal triamcinolone implant for the treatment of diabetic macular edema over a three-year period.

Timeline

Start
2005-06
Primary completion
2009-04
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified 925 ug Intravitreal